CLABSI Management — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — IV vancomycin (pending sensitivities)
CLABSI with coagulase-negative staphylococci in oncology patients: IV vancomycin is first-line pending sensitivities (high rates of methicillin resistance in CoNS). Line removal is considered if: failure to clear within 72 hours, fungal CLABSI, tunnel infection, or S. aureus CLABSI.
Reference: RCH Melbourne – 2024 – Clinical Practice Guidelines: CLABSI in Oncology